SATORI PHARMACEUTICALS INC — Form D
SATORI PHARMACEUTICALS INC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2012-02-23. The offering totals $19.2M, of which $15.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-02-23
- Form: D
- Accession: 0001329516-12-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $19.2M
- Amount sold: $15.0M
- Remaining: $4.2M
- Date of first sale: 2012-02-10
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-173852
Issuer
- Name: SATORI PHARMACEUTICALS INC
- CIK: 0001329516
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 281 ALBANY STREET, CAMBRIDGE, MA, 02139
- Phone: 6175470661
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Chris Ehrlich | Director | South San Francisco, CA |
| Jeffrey Ives | Director | Groton, CT |
| Edward Mathers | Director | South San Francisco, CA |
| Stephen Muniz | Director | Cambridge, MA |
| David Schnell | Director | New York, NY |
| Bennett Shapiro | Director | Cambridge, MA |
| Jeffrey Ives | Executive Officer | Groton, CT |
| Steven Holtzman | Director | BOSTON, MA |
| Daphne Zohar | Director | Boston, MA |
| Ilan Zipkin | Director | OAKLAND, CA |
| Christopher Ehrlich | Director | Cambridge, MA |
Other filings by this issuer (2)
More